HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zarrine-Afsar, A. Articles by Davidson, A. R. Search for Related Content PubMed PubMed Citation Articles by Zarrine-Afsar, A. Articles by Davidson, A. R. Social Bookmarking                   What's this?

Protein stabilization by specific binding of guanidinium to a functional arginine-binding surface on an SH3 domain

¹ Departments of Biochemistry, ² Molecular and Medical Genetics, and ³ Chemistry, University of Toronto, Toronto, Ontario, M5S-1A8, Canada

(RECEIVED September 1, 2005; FINAL REVISION September 1, 2005; ACCEPTED October 11, 2005)

Guanidinium hydrochloride (GuHCl) at low concentrations significantly stabilizes the Fyn SH3 domain. In this work, we have demonstrated that this stabilizing effect is manifested through a dramatic (five- to sixfold) decrease in the unfolding rate of the domain with the folding rate being affected minimally. This behavior contrasts to the effect of NaCl, which stabilizes this domain by accelerating the folding rate. These data imply that the stabilizing effect of GuHCl is not predominantly ionic in nature. Through NMR studies, we have identified a specific binding site for guanidinium, and we have determined a dissociation constant of 90mMfor this interaction. The guanidinium-binding site overlaps with a functionally important arginine-binding pocket on the domain surface, and we have shown that GuHCl is a specific inhibitor of the peptide-binding activity of the domain. A different SH3 domain possessing a similar arginine-binding pocket is also thermodynamically stabilized by GuHCl. These data suggest that many proteins that normally interact with arginine-containing ligands may also be able to specifically interact with guanidinium. Thus, some caution should be used when using GuHCl as a denaturant in protein folding studies. Since arginine-mediated interactions are often important in the energetics of protein–protein interactions, our observations could be relevant for the design of small molecule inhibitors of protein–protein interactions.

Keywords: SH3 domain; protein folding kinetics; guanidinium-induced protein stabilization; peptide binding; arginine–protein interaction; specific guanidinium binding

Article and publication are at http://www.proteinscience.org/cgi/doi/10.1110/ps.051829106.

Reprint requests to: Alan R. Davidson, Department of Molecular and Medical Genetics, University of Toronto, Toronto, Ontario M5S-1A8, Canada; e-mail alan.davidson{at}utoronto.ca; fax (416) 978-6885.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. F. Latypov, D. Liu, K. Gunasekaran, T. S. Harvey, V. I. Razinkov, and A. A. Raibekas Structural and thermodynamic effects of ANS binding to human interleukin-1 receptor antagonist Protein Sci., April 1, 2008; 17(4): 652 - 663. [Abstract] [Full Text] [PDF]

				K. L. Schweiker, A. Zarrine-Afsar, A. R. Davidson, and G. I. Makhatadze Computational design of the Fyn SH3 domain with increased stability through optimization of surface charge charge interactions Protein Sci., December 1, 2007; 16(12): 2694 - 2702. [Abstract] [Full Text] [PDF]